Your browser does not support JavaScript!
國立中國醫藥研究所
國立中國醫藥研究所
最新成果發表

[黃怡超]-Yang, Y.Y., Tsai, T.H., Huang,Y.T., Lee, T.Y., Chan, C.C.,Lee, K.C.,Lin, H.C.
Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
Hepatology, 55:1540-1550, 2012.
黃怡超成果發表圖一
 

[黃怡超]-Fan, T.P., Deal, G., Koo,  H.L., Rees, D., Sun, H., Chen, S., Dou, J.H., Makarov, V.G., Pozharitskaya, O.N., Shikov, A.N., Kim, Y.S.,
Huang, Y.T., Chang,Y.S., Jia, W., Dias, A., Wong, V.C., Chan, K.

Future development of global regulations of Chinese herbal products.
J. Ethnopharmacol., 140:568-586, 2012.

黃怡超成果發表圖一

[鄭靜枝]-Akselsen, O.W., Odlo, K., Cheng, J.J., Maccari, G., Botta,
M., Hansen, T.V.

Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.
Bioorg. Med. Chem., 20:234-242, 2012.
 
鄭靜枝成果發表

[黃乃] -Kuo, T.Y., Huang, C.L., Yang, J.M., Huang, W.J., Huang, N.K., Chen, Y.W., Lin, R.J., Yang, Y.C.
The role of ribosylated-BSA in regulating PC12 cell viability.
Cell Biol. Toxicol., in press, 2012.
 黃乃瑰成果圖黃乃瑰成果圖黃乃瑰成果發表圖一

 

數據載入中...